AUM Ventures has unveiled its second fund, the India Innovation Fund II, with a hefty ₹750 crore to back deeptech startups in India. This move comes at a time when the healthcare sector is increasingly reliant on technological advancements to address systemic challenges exacerbated by the pandemic. The fund aims to fill a significant financing gap, particularly for startups focused on medtech and diagnostics, which are crucial for improving healthcare delivery in the country.
The emphasis on deeptech is not just a trend; it reflects a growing recognition of the need for transformative solutions in healthcare. As the Indian healthcare system grapples with inefficiencies and accessibility issues, innovative technologies can play a pivotal role in reshaping patient care and operational efficiency. AUM Ventures is betting on startups that leverage AI, machine learning, and other advanced technologies to create scalable solutions.
Investors are keenly watching this space, as the pandemic has accelerated the adoption of digital health solutions. The fund's focus on deeptech aligns with global trends where healthcare innovation is increasingly driven by technology. AUM Ventures' strategy could position it as a key player in the burgeoning Indian healthtech landscape, potentially attracting further investments into the sector.
